Search Results

You are looking at 1 - 9 of 9 items for :

  • P. aeruginosa x
  • Internal Medicine, other x
Clear All
Open access

Christopher Egbe, Raphael Mordi, Richard Omoregie and Onaiwu Enabulele

Practice in Developing Country: a profile of met and unment needs. East Central Afri J Surg. 2008;13(2):101-104. Block SL. Causative pathogens, antibiotic resistance and therapeutic considerations in acute otitis media. Pediatr Infect Dis J. 1997;16(4):449-56. doi:10.1097/00006454-199704000-00029 PMID:9109158. Supiyanphun P, Luengvarinkul S. Mycotic infection of the middle ear and temporal bone. Srinagarind Hosp Med J. 1987;2(1):62-68. Koksal V, Reisli I. Acute otitis media in children. J

Open access

Mirjana A. Janicijevic-Petrovic, Snezana Jancic, Katarina Janicijevic and Andrijana Popovic

. Perilesional linear atrophy and hypo-pigmentation after intralesional corticosteroid therapy. Report of two cases and review of the literature. J Am Acad Dermatol. 1988; 19(3):537-41. 5. Oikarinen A, Autio P. New aspects of the mechanism of corticosteroid-induced dermal atrophy. Clin Exp Dermatol 1991Nov; 16(6):416-9. 6. Ben Simon GJ, Huang L, Nakra T, Schwarcz RM, McCann JD, Goldberg RA. Intralesional triamcinolone acetonide injection for primary and recurrent chalazia: is it really effective? Ophthalmology. 2005; 112

Open access

E. Kontonasaki, A. Bakopoulou, A. Theocharidou, G. S. Theodorou, L. Papadopoulou, N. Kantiranis, M. Bousnaki, C. Chatzichristou, E. Papachristou, K.M. Paraskevopoulos and P. Koidis

References 1. Rubin H . The logic of the membrane, magnesium, mitosis (MMM) model for the regulation of animal cell proliferation. Arch Biochem Biophys , 2007; 458:16-23. 2. Wolf FI, Fasanella S, Tedesco B, Torsello A, Sgambato A, Faraglia B, Palozza P, Boninsegna A, Cittadini A . Regulation of magnesium content during proliferation of mammary epithelial cells (HC-11). Front Biosci , 2004; 9:2056-2062. 3. Wallach S . Effects of magnesium on skeletal metabolism. Magnes Trace Elem, 1990; 9:1-14. 4. Rude RK, Olerich M . Magnesium

Open access

Neveen Helmy Abou El-Soud

References 1. The Landmark report on public perceptions of alternative care. Sacramento: Landmark Healthcare Inc., 1998. 2. Wilkinson JM,Simpson MD. High use of complementary therapies in a New South Wales rural community. Aust J Rural Health. 2001;9:166-71. 3. Thomas KJ, Nicoll JP, Coleman P. Use and expenditure on complementary medicine in England: a population based survey. Complement Ther Med. 2001;9:2-11. 4. Ransome HM. The Sacred Bee in Ancient Times and Folklore. London: George Allen and

Open access

Patrick M. Honore, Rita Jacobs, Olivier Joannes-Boyau, Willem Boer, Elisabeth De Waele, Viola Van Gorp and Herbert D. Spapen

References 1. Spapen HD, Jacobs R, Van Gorp V, Troubleyn J, Honoré PM. Renal and neurological side effects of colistin in critically ill patients. Ann Intensive Care 2011;1:14. 2. Bergen PJ, Li J, Rayner CR, Nation RL. Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa.Antimicrob Agents Chemother 2006;50:1953-8. 3. Couet W, Grégoire N, Marchand S, Mimoz O. Colistin pharmacokinetics: The fog is lifting. Clin Microbiol Infect 2012;18:30-9. 4. Yahav D

Open access

Vishal Sehgal, Sukhminder Jit Singh Bajwa, John A. Consalvo and Anurag Bajaj

References 1. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003;29:530-8. 2. Starr ME, Saito H. Sepsis in old age: review of human and animal studies. Aging Dis 2014;5:126-36. 3. Sehgal V, Bajwa SJ, Bajaj A. New orally active anticoagulants in critical care and anesthesia practice: The good, the bad and the ugly. Ann Card Anaesth 2013;16:193-200. 4. Kalra BS. Cytochrome P450 enzyme

Open access

Caterina Delcea, Camelia Badea, Ciprian Jurcut, Adrian Purcarea, Silvia Sovaila, Emma Weiss, Elena Alistar, Horia Balan and Cristian Baicus

.N., RYAN, C., GALLAGHER, P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2 . Age Ageing 2014; 44 (2):213–218. 17. HILL-TAYLOR, B., WALSH, K.A., STEWART, S., HAYDEN, J., BYRNE, S., SKETRIS, I.S. Effectiveness of the STOPP/START (Screening Tool of Older Persons’ potentially inappropriate Prescriptions/Screening Tool to Alert doctors to the Right Treatment) criteria: systematic review and meta-analysis of randomized controlled studies . J. Clin. Pharm. Ther. 2016; 41 (2):158–169. 18. BY THE AMERICAN GERIATRICS SOCIETY

Open access

Ying-gang Zhu, Xiao-dan Tang, Yun-tao Lu, Jing Zhang and Jie-ming Qu

shown in Figure 2 . Mycoplasmapneumoniae was the most common agent among adults, identified in 15.01% of patients, followed by Streptococcuspneumoniae in 11.68%, Influenza virus A in 12.28% and fungi in 8.28%. On the other hand, Mycoplasmapneumoniae was also the most common agent among children, identified in 19.16% of patients, followed by Respiratorysyncytial virus in 16.01%, Streptococcuspneumoniae in 9.44% and Klebsiellapneumoniae in 7.77%. Specifically, significant differences on the detected rate of Escherichiacoli and Pseudomonas aeruginosa were

Open access

Andrei-Marian Feier, Andrei-Constantin Ioanovici, Radu-Cristian Ionescu, Tamas Toth and Octav-Marius Russu

J Antimicrob Agents . 2013;42:519-523. 17. Balaban N, Cirioni O, Giacometti A, et al. Treatment of Staphylococcus aureus biofilm infection by the quorum-sensing inhibitor RIP. Antimicrob Agents Chemother . 2007;51:2226-2229. 18. Francolini I, Norris P, Piozzi A, et al. Usnic acid, a natural antimicrobial agent able to inhibit bacterial biofilm formation on polymer surfaces. Antimicrob Agents Chemother . 2004;48:4360-4365. 19. Rasamiravaka T, Labtani Q, Duez P, et al. The formation of biofilms by Pseudomonas aeruginosa: a review of the natural